Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K211004
    Date Cleared
    2021-05-13

    (41 days)

    Product Code
    Regulation Number
    888.3560
    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Evolis/GMK knee prosthesis is designed for cemented use in total knee arthroplasty, if there is evidence of sufficient sound bone to seat and support the components. This knee replacement system is indicated in the following cases:

    • · Severely painful and/or disabled joint as a result of arthritis, traumatoid arthritis or polyarthritis.
    • Avascular necrosis of femoral condyle.
    • · Post traumatic loss of joint configuration.
    • · Primary implantation failure.

    Tibial wedges cemented are to be attached to the tibial baseplate with both the fixing cylinders and bone cement. The screwed tibial augments are for screwed fixation to the tibial baseplate.

    In case a semi-constrained liner is used, an extension stem must be implanted both on the femoral components. In case a GMK Revision tibial tray is used, an extension stem must be implanted.

    GMK Sphere/Spherika can be implanted using a kinematic alignment approach. When a kinematic alignment approach is utilized, this knee replacement system is indicated in the following cases:
    · Severely painful and/or disabled joint as a result of arthritis, traumatoid arthritis, rheumatoid arthritis.

    • · Collagen disorders, and/or avascular necrosis of the femoral condyle.
    • · Moderate valgus, varus, or flexion deformities.
    Device Description

    The purpose of this submission is to notify the FDA of the GMK SPHERE range Extension, that includes GMK Spherika Femurs and GMK Fixed Tibial Trays Plus.

    Subject devices are sterile implantable devices designed for tricompartment of the natural knee joint.

    The subject devices are marketed as individually packaged femoral and tibial components, designed for cemented use in total knee arthroplasty procedures.

    GMK Spherika femoral component is an implantable device intended to be used in case of total knee arthroplasty to replace the femoral articular surfaces of the knee joint. GMK Spherika femoral component can be used in Kinematic Alignment surgical technique. The Kinematic Alignment surgical technique was already cleared in K173890.

    GMK Tibial Trays Plus are a range extension of the GMK Tibial trays already cleared, in details they are fixed intermediate sizes of the tibia trays.

    The subject devices are a line extension to Medacta previously cleared implants: GMK Sphere (K121416), GMK Sphere Extension (K140826), GMK Knee Prosthesis- GMK Sphere Tibial Insert Flex (K162035), GMK Sphere - Kinematic Alignment ( K173890), GMK Sphere CR Tibial Inserts (K181635), GMK Sphere E-Cross (K202022), GMK Total Knee System-TiNbN Coating (K202684), Medacta International SA, GMK Total Knee System (K090988), GMK Line Extension (K120790), GMK Narrow K122232, MK Extension (K142069) and

    The subject devices are manufactured with the same materials of the previous cleared femurs and tibial trays.

    The submission includes the following implants:

    • . GMK Spherika Femoral Component Cemented, Left and Right, Sizes from 1 to 7 and from 1+ to 6+ made in Co-Cr-Mo (ISO 5832-4)
    • . GMK Spherika Femoral Component Cemented, Left and Right, Sizes from 1 to 7 and from 1+ to 6+ made in Co-Cr-Mo (ISO 5832-4) and TiNbN Coated
    • . GMK Spherika Femoral Component Anatomical, Cemented, Left and Right, Sizes from 1 to 7 and from 1+ to 6+ made in Co-Cr-Mo (ISO 5832-4)
    • GMK Spherika Femoral Component Anatomical, Left and Right, Sizes from 1 to 7 and . from 1+ to 6+ made in Co-Cr-Mo (ISO 5832-4) and TiNbN Coated
    • Tibial tray fixed cemented, Left and Right, Sizes from 1+ to 5+ plus 4 intermediate sizes ● made in Co-Cr-Mo (ISO 5832-4)
    • Tibial tray fixed cemented, Left and Right, Sizes from 1+ to 5+ plus 4 intermediate sizes made in Co-Cr-Mo (ISO 5832-4) and TiNbN Coated

    The subject devices, both Femoral Components and Tibial Trays, are manufactured from cobaltchromium-molybdenum alloy (Co-Cr-Mo) according to ISO 5832-4:2014 Implants for Surgery -Metallic Materials-Part 4: Cobalt-Chromium-Molybdenum Casting Allov.

    In regards to the Femurs and Tibial Trays TiNbN Coating, they are manufactured from cobaltchromium-molybdenum alloy (Co-Cr-Mo) according to ISO 5832-4:2014 Implants for Surgery -Metallic Materials-Part 4: Cobalt-Chromium-Molybdenum Casting Alloy with Titanium Niobium Nitride (TiNbN) coating.

    Like the predicate tibial trays devices, the tibial trays plus subject of this submission have a Fixed Tibial Tray Plug that is manufactured from Type 1 Ultra High Molecular Weight Polyethylene (UHMWPE) per ISO 5834-2: 2019 Implants for Surgery - Ultra-High-Molecular-Weight Polyethylene -Part 2: Moulded Forms.

    The subject device also includes the utilization of the GMK Sphere E-cross tibial insert FLEX, already cleared (K202022) in case of retention of an efficient posterior cruciate ligament in the Kinematic Alignment configuration.

    The Kinematic Alignment surgical technique was already cleared in K173890.

    In this case there are no new implants or instruments, GMK Sphere E-cross tibial insert FLEX, already cleared (K202022).

    AI/ML Overview

    The provided text describes mechanical performance tests for knee implants, not a study evaluating an AI/ML powered device. Therefore, it does not contain the information requested in your prompt regarding acceptance criteria, study details, ground truth, or human-in-the-loop performance for an AI/ML device.

    The document is a 510(k) summary for a submission by Medacta International SA for a knee prosthesis, the "GMK-SPHERE Spherika Femurs and Tibial Trays plus". It focuses on demonstrating substantial equivalence to already cleared predicate devices through design comparisons and non-clinical mechanical testing, which is typical for traditional (non-AI/ML) medical devices.

    No information about an AI/ML device, its acceptance criteria, or a study proving those criteria are met is present in this regulatory document.

    Ask a Question

    Ask a specific question about this device

    K Number
    K201343
    Date Cleared
    2020-07-10

    (51 days)

    Product Code
    Regulation Number
    888.3560
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K172524, K173890, K193515

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    General Total Knee Arthroplasty (TKR) Indications:

    · Painful, disabling joint disease of the knee resulting from: noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.

    · Post-traumatic loss of knee joint configuration and function.

    · Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability.

    · Revision of previous unsuccessful knee replacement or other procedure.

    · Fracture of the distal femur and/or proximal tibia that cannot be standard fracture-management techniques.

    The Triathlon Tritanium Tibial Baseplate and Tritanium Metal-Backed Patella components are indicated for both uncemented and cemented use.

    The Triathlon Total Knee System beaded with Peri-Apatite components are intended for uncemented use only.

    The Triathlon All Polyethylene tibial components are indicated for cemented use only.

    Additional Indications for Posterior Stabilized (PS) Components:

    • · Ligamentous instability requiring implant bearing surface geometries with increased constraint.
    • · Absent or non-functioning posterior cruciate ligament.
    • · Severe anteroposterior instability of the knee joint.
    Device Description

    This submission covers Mako Total Knee Application-compatible components of the Triathlon® Total Knee System intended for use with the Mako System during a total knee arthroplasty. These include cruciate-retaining (CR), condylar stabilized (CS) and posterior stabilized (PS) components, tibial baseplates and TS tibial inserts. Triathlon® Total Knee System PSR tibial inserts are being reviewed for compatibility with the Mako Total Knee Application under K193515. The Triathlon® Total Knee System components have been previously cleared in prior 510(k) submissions and are commercially available. The Mako Total Knee Application-compatible Triathlon® Total Knee System components are manufactured from the following materials: Cobalt Chromium Alloy, Titanium Alloy, Commercially Pure Titanium, Ultra-High Molecular Weight Polyethylene and Calcium Phosphate.

    AI/ML Overview

    This FDA 510(k) summary for the Triathlon® Total Knee System (K201343) does not describe a study involving an AI/CADe device and therefore does not include the requested information about acceptance criteria or a study proving device performance against such criteria in the context of AI.

    The submission is for the addition of an individualized alignment preoperative planning methodology for the Triathlon® Total Knee System components used in conjunction with the Mako System during total knee arthroplasty. The Mako System itself (a robotic arm assisted surgery system) is not the subject of this 510(k), but rather the specific set of knee replacement components compatible with its planning application.

    The document indicates that:

    • The Triathlon® Total Knee System components have been previously cleared.
    • This submission focuses on compatibility and an individualized alignment preoperative planning method for these components.
    • Non-clinical laboratory assessments were previously performed on the components.
    • Clinical testing was not required as a basis for substantial equivalence for this specific submission.

    Therefore, I cannot provide the requested information. The document explicitly states "Clinical testing is not required as a basis for substantial equivalence," meaning no new clinical study was conducted for this specific submission to demonstrate performance against acceptance criteria for an AI or CADe device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1